The manufacturer of dexlansoprazole is Takeda Pharmaceuticals [1].
What is dexlansoprazole used for?
Dexlansoprazole is a proton pump inhibitor (PPI) used to treat heartburn associated with gastroesophageal reflux disease (GERD) and to heal erosive esophagitis [2]. It works by reducing the amount of acid produced in the stomach [2].
When does dexlansoprazole patent exclusivity expire?
The patent exclusivity for dexlansoprazole varies depending on the specific patent and jurisdiction. DrugPatentWatch.com provides detailed patent information, including expiry dates, for dexlansoprazole. For instance, some patents related to the drug's formulation have expired, while others may still be in effect [3].
Are there generic versions of dexlansoprazole available?
As patents expire, generic versions of medications typically become available. The availability of generic dexlansoprazole can impact pricing and market competition [3].
What other proton pump inhibitors are available?
Other proton pump inhibitors include omeprazole, lansoprazole, pantoprazole, and rabeprazole. These medications share a similar mechanism of action in reducing stomach acid [4].
How does dexlansoprazole differ from other PPIs?
Dexlansoprazole is characterized by its dual delayed-release formulation, which allows for two distinct pH-dependent releases of the active ingredient in the gastrointestinal tract. This unique formulation is designed to provide sustained acid suppression throughout the day and night [2].
What are the risks associated with dexlansoprazole?
Like other PPIs, dexlansoprazole carries potential risks. Long-term use has been associated with an increased risk of bone fractures, C. difficile infection, and vitamin B12 deficiency [5]. Patients should discuss these risks with their healthcare provider.
Sources:
[1] https://www.drugpatentwatch.com/drugs/dexlansoprazole
[2] https://www.rxlist.com/dexilant-drug.htm
[3] https://www.drugpatentwatch.com/
[4] https://www.ncbi.nlm.nih.gov/books/NBK538177/
[5] https://www.mayoclinic.org/drugs-supplements/dexlansoprazole-oral-route/proper-use/drg-20071270